جدول الترويج CalciMedica, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. مزيد من التفاصيل| IPO date | 2020-09-25 |
|---|---|
| ISIN | US38942Q2021 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.calcimedica.com |
| Цена ао | 1.99 |
| تغير السعر يوميا: | -3.86% (2.07) |
|---|---|
| تغير السعر في الأسبوع: | -0.995% (2.01) |
| تغير السعر شهريا: | -13.85% (2.31) |
| تغير السعر خلال 3 أشهر: | -30.18% (2.85) |
| تغير السعر على مدى ستة أشهر: | -55.08% (4.43) |
| تغير السعر سنويا: | -52.16% (4.16) |
| تغير السعر على مدى 3 سنوات: | +48.51% (1.34) |
| تغير الأسعار منذ بداية العام: | -27.11% (2.73) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Orbimed Advisors LLC. | 297380 | 5.25 |
| Bml Capital Management, LLC | 145424 | 2.57 |
| Meritage Portfolio Management | 46000 | 0.81 |
| Geode Capital Management, LLC | 13354 | 0.24 |
| First Manhattan Company | 13226 | 0.23 |
| Tower Research Capital LLC (TRC) | 1417 | 0.03 |
| Morgan Stanley | 856 | 0.02 |
| Bank of America Corporation | 507 | 0.01 |
| Wells Fargo & Company | 16 | 0 |
| Cutler Group LP | 14 | 0 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Dr. A. Rachel Leheny Ph.D. | CEO & Director | 852.84k | 1963 (62 سنة) |
| Mr. Eric W. Roberts | Chief Business Officer & Vice Chairman of the Board | 757.4k | 1964 (61 سنة) |
| Dr. Anjana Rao Ph.D. | Co-Founder and Scientific Advisor | N/A | |
| Dr. Patrick Hogan Ph.D. | Co-Founder and Scientific Advisor | N/A | |
| Dr. Stefan Feske M.D. | Co-Founder and Scientific Advisor | N/A | |
| Dr. Kenneth A. Stauderman Ph.D. | Co-Founder & Chief Scientific Officer | 615.59k | 1953 (72 سنة) |
| Mr. Daniel E. Geffken M.B.A. | Interim Chief Financial Officer | N/A | 1957 (68 سنين) |
| Mr. John M. Dunn J.D. | General Counsel | N/A | 1952 (73 سنة) |
| Mr. Michael J. Dunn M.B.A., MBA | President & COO | N/A | 1956 (69 سنين) |
| Dr. Sudarshan Hebbar M.D. | Chief Medical Officer | 1965 (60 سنين) |
عنوان: United States, La Jolla. CA, 505 Coast Boulevard South - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.calcimedica.com
موقع إلكتروني: https://www.calcimedica.com
